Loading...

Photocure ASA

PHCUFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$6.00
$0.00(0.00%)

Photocure ASA (PHCUF) Company Profile & Overview

Explore Photocure ASA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Photocure ASA (PHCUF) Company Profile & Overview

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEODaniel Schneider

Contact Information

47 22 06 22 10
Hoffsveien 4, Oslo, 0275

Company Facts

99 Employees
IPO DateSep 24, 2013
CountryNO
Actively Trading

Frequently Asked Questions

;